Advanced therapy medicinal products
29 results
Applied filters
Horizon scanning for ATMPs
13 June 2023Describes what horizon scanning is, how it is performed for the NHS and it's importance for ATMPs.
Pharmacy Manual Checklist for Clinical Trials for ATIMPs
2 March 2023Pharmacy Manual content expectations for optimal site implementation of ATIMP Clinical Trials.
Accessing the CAR-T training passport for clinical pharmacists
28 February 2023The Pan UK Pharmacy Working Group for ATMPs has collaborated with UK BMT (Bone Marrow Transplant) pharmacists to produce a CAR-T verification passport
Outsourcing of Storage or Preparation of ATIMPs Across Legal Boundaries
15 November 2022Guidance on the considerations for Pharmacy Clinical Trial Sites outsourcing activities involved in the delivery of ATIMPs
Diagnosis and Medical Management of Acute CAR-T Cell Toxicities in Adults
16 September 2022Consensus guidance (involving Wave 1 and 2 CAR-T centres) on the management of acute CAR-T cell toxicities.
Operational Implications of UK Exit from the EU for NHS Clinical Trial Sites
16 September 2022A summary of the implications of the UKs exit from the EU for clinical trial sites for both IMP and ATIMPs, including supply to and from Northern Ireland
Outsourcing the Receipt, Storage, Preparation and Onward Supply of Marketed Cryopreserved ATMPs - A Template Technical Agreement
26 August 2022A template Quality Technical Agreement for Outsourcing the Receipt, Storage, Preparation and Onward Supply of Marketed Cryopreserved ATMPs.
Medication Restrictions for Patients Having CAR-T Cell Therapy V5
12 July 2022CAR-T Therapy requires some medicines to be restricted, this guidance provides details and recommended wash-out periods for restricted medicines.
Costing Clinical Trials of ATIMPs using the NIHR iCT - Advice for Pharmacy Sites
12 July 2022Guidance to support and promote consistent pharmacy costing for commercial clinical trials involving ATIMPs.
Supportive Medicines for Adults Receiving Marketed CAR-T Cell Therapy
12 July 2022This document provides expert clinical pharmacy guidance on supportive medicines in order to facilitate the treatment of complex CAR-T Cell Therapy patients.